Aandeel LBPH LONGBOARD PHARMACEUTICALS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Longboard Pharmaceuticals, Inc.

Aandelen

LBPH

US54300N1037

Beurs gesloten - Nasdaq
Andere beurzen
 22:00:00 23-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
20,21 USD +8,25% Intraday-grafiek van Longboard Pharmaceuticals, Inc. +10,74% +235,16%
12/03 Longboard Pharmaceuticals, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
16/01 LONGBOARD PHARMACEUTICALS, INC. : Cantor Fitzgerald bevestigt koopadvies ZM

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding
Longboard Pharmaceuticals, Inc.(NasdaqGM:LBPH) added to S&P Pharmaceuticals Select Industry Index
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
LONGBOARD PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS OPTION TO PURCHASE ADDITIONAL SHARES
Longboard Pharmaceuticals Closes $242 Million Public Offering
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Longboard Pharmaceuticals Prices $210 Million Stock Offering
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
LONGBOARD PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE DATA FROM THE PACIFIC STUDY, A PHASE 1B/2A CLINICAL TRIAL, FOR BEXICASERIN IN PARTICIPANTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES
Longboard Pharmaceuticals Launching Share Offering
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
Sector Update: Health Care Stocks Gain Late Afternoon
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers LBPH
  4. Nieuws Longboard Pharmaceuticals, Inc.
  5. Andere talen